KALAMAZOO, Mich. (WNDU) — Pfizer is investing $120 million to support production of its COVID antiviral treatment in southwest Michigan.
PAXLOVID has been called a “game changer” in the pandemic. It works best when used within a few days of symptom onset and may reduce the risk of serious illness.
The pharmaceutical company routes the money to its manufacturing plant in Kalamazoo. Pfizer says the funds will help expand production of the active ingredient and registered raw materials.
This money will also create 250 additional jobs at the Kalamazoo site.
“This is just one more step in our battle to defeat COVID-19 to keep people safe and healthy,” Michigan Governor Gretchen Whitmer said. “And Pfizer has been at the forefront of this work. And we are excited about this further investment here in Michigan.
12 million treatment courses have been shipped to 37 countries. That includes five million here in the United States
In total, nearly 17 million courses of PAXLOVID have been manufactured.
Michigan Governor’s Executive Office Press Release:
Today Governor Whitmer joined Pfizer Inc. announcing that it will further strengthen its commitment to Michigan manufacturing with a $120 million investment in its Kalamazoo, Michigan plant, enabling production in the United States in support of its oral COVID-19 treatment, PAXLOVID , which will create more than 250 specialized jobs at Pfizer’s Kalamazoo site. This investment builds on Governor Whitmer’s commitment to growing Michigan’s economy and creating well-paying jobs for Michiganians across the state.
“Pfizer’s $120 million expansion in Kalamazoo, creating 250 well-paying jobs, making PAXLOVID will save lives and build on Michigan’s economic momentum,” said Governor Gretchen Whitmer. “Pfizer’s Kalamazoo facility also manufactured some of the first doses of the vaccine, and now this proud Michigan company will play a critical role in both treating and preventing COVID. By creating opportunity for the people of Michigan, Pfizer helps us grow our economy, create well-paying jobs, and keep families safe. »
This investment is another step in Pfizer’s efforts to bring more key biopharmaceutical manufacturing to the United States, increasing Pfizer’s ability to produce and deliver treatments and medicines to patients in the United States and around the world.
“Pfizer Global Supply has made the impossible possible, creating billions of doses of vaccines and now millions of treatments to help combat the deadly COVID-19 pandemic,” said Albert Bourla, Chairman and CEO, Pfizer. “By increasing production at our Michigan facility, we are both helping patients around the world and extending important manufacturing innovations to the United States. This investment builds on our $5 billion in investments in our manufacturing and distribution portfolio since 2017 to support continued growth in U.S. manufacturing leadership.”
To date, Pfizer has manufactured more than 5.5 million packs of PAXLOVID worldwide in 26 countries, including 1.3 million courses shipped to the United States. This significant investment will allow Pfizer to expand PAXLOVID supply capacity as needed to meet global demand. With this new investment, Kalamazoo will be one of the world’s largest producers of Active Pharmaceutical Ingredients (APIs), with a production capacity of 1,200 metric tons per year.
Pfizer also plans to expand its modular aseptic processing (MAP) sterile injectable pharmaceutical production facility in Kalamazoo with a phase two investment. The expansion adds to the initial $450 million investment in the first phase to build a 400,000 square foot production facility and establishes Kalamazoo as one of the most advanced sterile injectable pharmaceutical production facilities technically in the world.
“Pfizer’s Kalamazoo plant has been at the forefront of pharmaceutical manufacturing for more than 135 years thanks to the former Upjohn company,” said Mike McDermott, Director of Global Sourcing, Pfizer. “The Kalamazoo plant utilizes some of our most innovative manufacturing technologies and has played a critical role in Pfizer’s fight against COVID-19, producing more than one billion doses of COVID-19 vaccine to date. 19 on the website. Through this expansion, we will continue to invest in the next generation of manufacturing and supply chain resilience. »
Governor’s Whitmer Economic Development
In December, Governor Whitmer brought together the two parties and public and private sector partners and signed landmark economic development legislation that allowed Michigan to compete for every project and every job. In January, weeks after the fund was established, Michigan fought to secure a $7 billion investment from GM – the largest in its history – creating and retaining 5,000 jobs. In March, LG Energy Solution invested $1.7 billion to create 1,200 jobs and last week Ford announced a $2 billion investment creating 2,200 jobs. There are more projects in the pipeline, and Governor Whitmer will work with anyone to bring more jobs and investment to Michigan.
Michigan’s Growing Economy
Governor Whitmer is focused on growing Michigan’s economy, creating well-paying jobs and cutting costs. Since she took office, Michigan has created nearly 25,000 auto jobs, including Detroit’s first plant in 30 years. She worked across the aisle to establish and fund two groundbreaking workforce development programs — Michigan Reconnect and Futures for Frontliners — putting tens of thousands of Michiganders on tuition-free paths. towards higher education or vocational training. Today, Michigan is growing, supported by billions of dollars in federal stimulus and additional revenue, effective fiscal management that has led to a budget surplus, and a pandemic unemployment rate of 4.3%. In the coming weeks, Governor Whitmer will work with the Legislature to introduce a balanced, bipartisan fourth budget that invests in the kitchen table priorities that matter most to Michigan families.
Learn more about Governor Whitmer’s economic accomplishments by clicking the following link Governor Whitmer’s Economic Achievements.
To learn more about Pfizer’s global manufacturing and sourcing, visit https://www.pfizer.com/products/how-drugs-are-made/global-supply.
Copyright 2022 WNDU. All rights reserved.